RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,081,000 | +69.7% | 58,993 | +2.7% | 0.10% | +83.6% |
| Q3 2019 | $637,000 | +305.7% | 57,463 | +83.6% | 0.06% | +400.0% |
| Q2 2018 | $157,000 | +72.5% | 31,303 | +207.1% | 0.01% | +57.1% |
| Q4 2015 | $91,000 | -83.8% | 10,194 | -78.2% | 0.01% | -82.5% |
| Q3 2015 | $561,000 | +40.6% | 46,673 | +50.9% | 0.04% | +33.3% |
| Q2 2015 | $399,000 | +200.0% | 30,929 | +110.4% | 0.03% | +233.3% |
| Q1 2015 | $133,000 | – | 14,701 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |